PA
CART icon

PharVision Advisers’s Maplebear CART Stock Holding History

PharVision Advisers’s Portfolio CART Stock Details CART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,468
Closed -$238K – 723
2025
Q3 		$238K Buy
+6,468
New +$298K 0.13% 368
2025
Q1 		– Sell
-5,611
Closed -$232K – 301
2024
Q4 		$232K Buy
+5,611
New +$243K 0.2% 244

Other funds holding CART

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GGH
GCM Grosvenor Holdings Chicago, Illinois $901M AUM 28.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PharVision Advisers's CART Position: Q4 2025 in Review

PharVision Advisers sold out of Maplebear (CART) in Q4 2025, closing a stake of 6,468 shares — an estimated $238K sold.

PharVision Advisers first reported a position in CART in Q4 2024 and held it in 2 quarters. The position peaked at $238K in Q3 2025. 445 funds tracked by Wall St. Rank hold CART as of Q4 2025.

  • PharVision Advisers reported no remaining Maplebear position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 6,468 Maplebear shares in Q4 2025, an estimated $238K.
  • PharVision Advisers first reported a position in Maplebear in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Maplebear position peaked at $238K in Q3 2025.
  • 445 funds tracked by Wall St. Rank held Maplebear as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.